Novartis | NVS - Capital De Empréstimo

Preço das Ações
146.03
Mudança Diária
-2.13 -1.44%
Mensal
-11.34%
Anual
30.22%
Q1 Previsão
142.44




Capital De Empréstimo Alterar Data
AbbVie USD 62.97B 12M 2025-09
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Bausch Health Companies USD 20.62B 152M 2025-12
Biogen USD 6.29B 1.4M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Canopy Growth CAD 224.99M 1.34M 2025-12
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Glaxosmithkline GBP 19.82B 203.13M 2025-12
J&J USD 39.44B 30M 2025-12
Merck USD 39.97B 6B 2025-09
Novartis USD 29.59B 5.35B 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Sanofi EUR 15.72B 150.06M 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Zoetis USD 9.04B 1.97B 2025-12